Patients, doctors, scientists deliver testimony to IDSA Review panel
By Phyllis Mervine, EdM
The ILADS team that made it happen
By Lorraine Johnson, JD, MBA
Leading Lyme organizations push for recognition of patient interests
By Diane Blanchard
Orchestrated presentations focus on clinical discretion and patient interests
By Lorraine Johnson, JD, MBA
IDSA overstatements, exclusions and speculation prevent proper diagnosis and treatment of Lyme
By International Lyme and Associated Diseases Society
Treatment options should allow clinical discretion in the face of uncertain science
By Lorraine Johnson, JD, MBA
Data confirm devastating impact of IDSA Guidelines on patient care
By Lorraine Johnson, JD, MBA
Critique of IDSA campaign to disseminate opinion and silence science regarding persistent Lyme
By David Volkman, MD
Physicians should be free to apply clinical judgement in the face of unsettled science
By Lyme Disease Association
Individual care for individual patients requires professional judgment
By Association of American Physicians and Surgeons
Recommends regional guidelines to allow adequate treatment options
By Lyme Disease Action
DBG registers objections to IDSA Lyme Guidelines
By Deutsche Borreliose-Gesellschaft (DBG)
Guidelines restrict research design and distort data on chronic Lyme
By Cheryl Koopman, PhD, and Daniel Cameron, MD
JOIN & RECEIVE ACCESS TOLYMETIMES
You don’t have access to the LymeTimes Summer 2009 Issue. Become a member and get immediate access to all LymeTimes issues.
Subscribe to our mailing list and get Lyme disease news updates to your email inbox.
We respect your privacy and take protecting it seriously.